Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting

Molnupiravir (MOV) and nirmatrelvir/ritonavir (NMV/r) are efficacious oral antiviral agents for patients with the 2019 coronavirus (COVID-19). However, little is known about their effectiveness in older adults and those at high risk of disease progression. This retrospective single-center observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutoh, Yoshikazu, Umemura, Takumi, Nishikawa, Takeshi, Kondo, Kaho, Nishina, Yuta, Soejima, Kazuaki, Noguchi, Yoichiro, Bando, Tomohiro, Ota, Sho, Shimahara, Tatsuki, Hirota, Shuko, Hagimoto, Satoshi, Takei, Reoto, Fukihara, Jun, Sasano, Hajime, Yamano, Yasuhiko, Yokoyama, Toshiki, Kataoka, Kensuke, Matsuda, Toshiaki, Kimura, Tomoki, Ichihara, Toshihiko, Kondoh, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054616/
https://www.ncbi.nlm.nih.gov/pubmed/36992519
http://dx.doi.org/10.3390/v15030811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054616/
https://www.ncbi.nlm.nih.gov/pubmed/36992519
http://dx.doi.org/10.3390/v15030811

Ejemplares similares